Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Verastem (VSTM) Equity Average (2018 - 2025)

Historic Equity Average for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to $10.3 million.

  • Verastem's Equity Average fell 3136.3% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 3136.3%. This contributed to the annual value of $67.5 million for FY2022, which is 3346.74% down from last year.
  • According to the latest figures from Q3 2025, Verastem's Equity Average is $10.3 million, which was down 3136.3% from $1.8 million recorded in Q2 2025.
  • Verastem's 5-year Equity Average high stood at $108.9 million for Q1 2021, and its period low was -$30.7 million during Q1 2025.
  • Its 5-year average for Equity Average is $50.5 million, with a median of $56.8 million in 2022.
  • Per our database at Business Quant, Verastem's Equity Average soared by 6740.01% in 2021 and then plummeted by 15665.64% in 2025.
  • Verastem's Equity Average (Quarter) stood at $91.6 million in 2021, then crashed by 39.82% to $55.1 million in 2022, then skyrocketed by 67.57% to $92.4 million in 2023, then tumbled by 109.65% to -$8.9 million in 2024, then skyrocketed by 215.12% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $1.8 million for Q2 2025, and -$30.7 million during Q1 2025.